These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11279527)

  • 1. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.
    Arikawa-Hirasawa E; Wilcox WR; Yamada Y
    Am J Med Genet; 2001; 106(4):254-7. PubMed ID: 11891676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and molecular characterization of a novel case of dyssegmental dysplasia, Silverman-Handmaker type.
    Rieubland C; Jacquemont S; Mittaz L; Osterheld MC; Vial Y; Superti-Furga A; Unger S; Bonafé L
    Eur J Med Genet; 2010; 53(5):294-8. PubMed ID: 20542149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwartz-Jampel syndrome and perlecan deficiency.
    Stum M; Davoine CS; Fontaine B; Nicole S
    Acta Myol; 2005 Oct; 24(2):89-92. PubMed ID: 16550923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.
    Arikawa-Hirasawa E; Le AH; Nishino I; Nonaka I; Ho NC; Francomano CA; Govindraj P; Hassell JR; Devaney JM; Spranger J; Stevenson RE; Iannaccone S; Dalakas MC; Yamada Y
    Am J Hum Genet; 2002 May; 70(5):1368-75. PubMed ID: 11941538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyssegmental dysplasia, Silverman-Handmaker type: A challenging antenatal diagnosis in a dizygotic twin pregnancy.
    Basalom S; Trakadis Y; Shear R; Azouz ME; De Bie I
    Mol Genet Genomic Med; 2018 May; 6(3):452-456. PubMed ID: 29526034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
    Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
    Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyssegmental dysplasia Rolland-Desbuquois type is caused by pathogenic variants in HSPG2 - a founder haplotype shared in five patients.
    Farshadyeganeh P; Yamada T; Ohashi H; Nishimura G; Fujita H; Oishi Y; Nunode M; Ishikawa S; Murotsuki J; Yamashita Y; Ikegawa S; Ogi T; Arikawa-Hirasawa E; Ohno K
    J Hum Genet; 2024 Jun; 69(6):235-244. PubMed ID: 38424183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan is essential for cartilage and cephalic development.
    Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
    Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).
    Nicole S; Davoine CS; Topaloglu H; Cattolico L; Barral D; Beighton P; Hamida CB; Hammouda H; Cruaud C; White PS; Samson D; Urtizberea JA; Lehmann-Horn F; Weissenbach J; Hentati F; Fontaine B
    Nat Genet; 2000 Dec; 26(4):480-3. PubMed ID: 11101850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the heparan sulfate proteoglycan perlecan on human disease and health.
    Arikawa-Hirasawa E
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1117-C1122. PubMed ID: 35417267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate of perlecan is involved in glomerular filtration.
    Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
    J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.
    Rossi M; Morita H; Sormunen R; Airenne S; Kreivi M; Wang L; Fukai N; Olsen BR; Tryggvason K; Soininen R
    EMBO J; 2003 Jan; 22(2):236-45. PubMed ID: 12514129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perlecan is critical for heart stability.
    Sasse P; Malan D; Fleischmann M; Roell W; Gustafsson E; Bostani T; Fan Y; Kolbe T; Breitbach M; Addicks K; Welz A; Brem G; Hescheler J; Aszodi A; Costell M; Bloch W; Fleischmann BK
    Cardiovasc Res; 2008 Dec; 80(3):435-44. PubMed ID: 18694874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome.
    Rodgers KD; Sasaki T; Aszodi A; Jacenko O
    Hum Mol Genet; 2007 Mar; 16(5):515-28. PubMed ID: 17213231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan-deficient mutation impairs corneal epithelial structure.
    Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on molecules: perlecan (HSPG2).
    Smith S; Hassell JR
    Exp Eye Res; 2006 Sep; 83(3):471-2. PubMed ID: 16549064
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of perlecan in skeletal development and diseases.
    Hassell J; Yamada Y; Arikawa-Hirasawa E
    Glycoconj J; 2002; 19(4-5):263-7. PubMed ID: 12975604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.